Literature DB >> 34674318

Endoscopic features and clinical importance of autoimmune gastritis.

Tomoari Kamada1, Yasuhiko Maruyama2, Yasumasa Monobe3, Ken Haruma4.   

Abstract

Autoimmune gastritis (AIG) is a special type of chronic gastritis characterized by autoimmune disorders caused by cellular immunity, resulting in the destruction of parietal cells and production of antiparietal cell antibodies. Endoscopic findings of AIG are mainly characterized by corpus-dominant advanced atrophy. The antral area is generally considered to have no or mild atrophy; however, there are cases wherein the gastric mucosa is red or faded due to past infection with Helicobacter pylori or bile reflux. Currently, there are no diagnostic criteria for AIG in Japan, and it is important to make a diagnosis based on the presence of gastric autoantibodies and characteristic endoscopic and histological findings. AIG is associated with gastric cancer, neuroendocrine tumors (NETs), and other autoimmune diseases, such as thyroid diseases, anemia, and neurological symptoms due to impaired absorption of iron and vitamin B12 , and thus requires systemic treatment. The significance of diagnosing AIG is to include patients as a high-risk group for the development of gastric cancer and gastric NETs, provide an opportunity to detect autoimmune endocrine diseases, and initiate therapeutic intervention before anemia and neurological symptoms develop. It is important to pay close attention to the occurrence of AIG comorbidities not only at the time of AIG diagnosis but also during follow-up after detection.
© 2021 Japan Gastroenterological Endoscopy Society.

Entities:  

Keywords:  autoimmune gastritis; autoimmune polyendocrine syndrome; corpus-predominant atrophy; gastric cancer; gastric neuroendocrine tumor

Mesh:

Year:  2021        PMID: 34674318     DOI: 10.1111/den.14175

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  6 in total

1.  Early autoimmune gastritis presenting with a normal endoscopic appearance.

Authors:  Tohru Kotera; Masayoshi Yamanishi; Ryoji Kushima; Ken Haruma
Journal:  Clin J Gastroenterol       Date:  2022-03-07

2.  Type-1 Grade 2 Multi-Focal Gastric Neuroendocrine Tumors Secondary to Chronic Autoimmune Gastritis.

Authors:  Ziqi Yu; Aiyao Wang; Chong Hu; Tao Yu; Jianyong Chen
Journal:  Front Med (Lausanne)       Date:  2022-06-17

3.  Characterization of Gastric Tissue-Resident T Cells in Autoimmune and Helicobacter pylori-Associated Gastritis.

Authors:  Daisuke Kametaka; Masaya Iwamuro; Takahide Takahashi; Araki Hirabata; Kenta Hamada; Yoshiyasu Kono; Hiromitsu Kanzaki; Seiji Kawano; Takehiro Tanaka; Fumio Otsuka; Yoshiro Kawahara; Hiroyuki Okada
Journal:  Curr Issues Mol Biol       Date:  2022-05-25       Impact factor: 2.976

Review 4.  Ferroptosis and its Role in Gastric Cancer.

Authors:  Renjun Gu; Yawen Xia; Pengfei Li; Defang Zou; Keqin Lu; Lang Ren; Hongru Zhang; Zhiguang Sun
Journal:  Front Cell Dev Biol       Date:  2022-06-30

Review 5.  Endoscopic Features of Autoimmune Gastritis: Focus on Typical Images and Early Images.

Authors:  Maiko Kishino; Kouichi Nonaka
Journal:  J Clin Med       Date:  2022-06-19       Impact factor: 4.964

6.  Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis.

Authors:  Hiroshi Kishikawa; Kenji Nakamura; Keisuke Ojiro; Tadashi Katayama; Kyoko Arahata; Sakiko Takarabe; Aya Sasaki; Soichiro Miura; Yukie Hayashi; Hitomi Hoshi; Takanori Kanai; Jiro Nishida
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.